Acute Lung Injury: all 994 studies
Page 5 of 10. Open to participants first (156), then studies with results posted, then the rest; newest registration first within each.
- Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced HypoxemiaCompletedNCT04990830Phase 2/3
- Nigelle 5 in Prevention of InfluanzaCompletedNCT04989101Not applicable
- Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control TrialStatus unknownNCT04979923Phase 1
- Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University HospitalCompletedNCT04979884Phase 3
- Cognitive Functions After COVID-19CompletedNCT04978246
- Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19Status unknownNCT04977960Phase 2
- Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired PneumoniaTerminatedNCT04972318Not applicable
- Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral ResponseStatus unknownNCT04961229Phase 4
- Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU PatientsStatus unknownNCT04956913
- Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19Status unknownNCT04954040Phase 2
- Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 PatientsTerminatedNCT04954014Phase 2
- A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.WithdrawnNCT04953052Phase 2
- Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical ResearchStatus unknownNCT04951882Early Phase 1
- A Retrospective Study of COVID-19 TreatmentsCompletedNCT04949230
- imPulse™ Una Infrasound-to-ultrasound E-stethoscopeCompletedNCT04941209
- Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICUCompletedNCT04941092
- Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung InjuryStatus unknownNCT04940676Phase 2
- The Mechanism of lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome Through miR-27b Regulated Nrf2 PathwayStatus unknownNCT04937855
- Pulmonary Inflammation in COVID-19 ARDSStatus unknownNCT04935450
- Cerebral Autoregulation and COVID-19TerminatedNCT04930874Not applicable
- Closed Loop Mechanical Ventilation and ECMOCompletedNCT04925518Not applicable
- A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)TerminatedNCT04922957Phase 2
- Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04909879Phase 2
- Perceptions and Representations of Vaccination Against COVID-19CompletedNCT04896957
- Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)CompletedNCT04896866Not applicable
- Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®Active, not recruitingNCT04896853Phase 1
- Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19CompletedNCT04894214
- Impact of Aerosol Box Use on Healthcare Provider ContaminationCompletedNCT04880668Not applicable
- Effect of S-ketamine Anesthetic on Inflammatory Response in Septic Patients Undergoing Abdominal SurgeryStatus unknownNCT04873479Not applicable
- Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration TherapyCompletedNCT04871893Not applicable
- Ultrasound Grayscale Analysis in ARDS covid19CompletedNCT04863534
- Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.Status unknownNCT04860687
- Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMOStatus unknownNCT04853953
- Phrenic Nerve Stimulation-Induced Lung ReAeration TrialCompletedNCT04844892Not applicable
- DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 PneumoniaStatus unknownNCT04836780Phase 3
- Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04818164
- Clinical Features of COVID-19 PatientsCompletedNCT04815304
- Prospective Electroencephalography Evaluation of Sedation in COVID-19CompletedNCT04815109
- The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19Status unknownNCT04798716Phase 1/2
- Intravenous Imatinib in Mechanically Ventilated COVID-19 PatientsTerminatedNCT04794088Phase 2
- Risk Factors for COVID-19 MortalityTerminatedNCT04786808
- Driving Pressure as a Predictor of Mortality in Acute Respiratory Distress Syndrome PatientsStatus unknownNCT04778228
- Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the ARDS Patients With Lung RecruitmentStatus unknownNCT04776408Not applicable
- Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19Status unknownNCT04760821Phase 2
- Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19CompletedNCT04745442Phase 2
- Roflumilast as add-on Therapy in Early Cases of ARDSCompletedNCT04744090Phase 2
- Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress SyndromeWithdrawnNCT04737161Phase 1
- Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress SyndromeCompletedNCT04725084
- Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS PatientsTerminatedNCT04715243Not applicable
- High-Dose Vitamin C Treatment in Critically Ill COVID-19 PatientsCompletedNCT04710329
- Tolerability and Efficacy of RJX in Patients With COVID-19Status unknownNCT04708340Phase 1/2
- The Effect of Preemptive APRV on Patients With High Risk for ARDSCompletedNCT04699513Not applicable
- Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS)CompletedNCT04696172
- The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) StudyCompletedNCT04693403Not applicable
- Biomarkers, Genomics, Physiology in Critically Ill and ECMO PatientsStatus unknownNCT04669444Not applicable
- Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndromeCompletedNCT04667923
- Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study PlatformCompletedNCT04663776
- Lung Ultrasound Score and Pediatric Intensive Care Outcomes (LUS-PICO)CompletedNCT04660448
- RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot StudyStatus unknownNCT04659460Not applicable
- Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19CompletedNCT04659109Phase 2
- Impact of Decreasing Respiratory Rate on Lung Injury Biomarkers in ARDS PatientsCompletedNCT04641897Not applicable
- Effects of Extravascular Lung Water on Prone Position Efficacy in Patients With ARDSStatus unknownNCT04635267
- Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress SyndromeCompletedNCT04625738Phase 2
- Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19CompletedNCT04619368
- FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 PneumoniaCompletedNCT04618042Phase 2
- SILtuximab in Viral ARds (SILVAR) StudyTerminatedNCT04616586Phase 3
- Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients RecoveryCompletedNCT04612608Not applicable
- Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04609943Phase 1
- Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaTerminatedNCT04609865Phase 3
- PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress SyndromeCompletedNCT04607551Not applicable
- Mechanism of Delayed Neutrophil Apoptosis in Acute Lung InjuryCompletedNCT04607434
- Electrical Impedance Tomography Monitoring and Invasive Mechanical Ventilation During Pronation in Acute Respiratory Distress Syndrome.Status unknownNCT04605133
- Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04603755
- A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDSCompletedNCT04602104Phase 1/2
- Survival Rates and Longterm Outcomes After COVID-19CompletedNCT04601090
- Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress SyndromeStatus unknownNCT04597853
- The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19WithdrawnNCT04588441Phase 2
- Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19Status unknownNCT04586114
- A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory FailureWithdrawnNCT04574869Phase 1
- Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICUCompletedNCT04569266Not applicable
- Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04568018
- Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart SurgeryCompletedNCT04562207Not applicable
- Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT04552821
- Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)CompletedNCT04548739
- Effect of R-spondin3 on Sepsis Induced Endothelial DysfunctionStatus unknownNCT04546919
- Trial of Therapeutic Hypothermia in Patients With ARDSActive, not recruitingNCT04545424Phase 2
- Radiomics Markers to Predict Sepsis Induced Acute Respiratory Distress SyndromeStatus unknownNCT04541264
- Driving Pressures in a Closed-loop and a Conventional Mechanical Ventilation ModeCompletedNCT04541199Not applicable
- The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying CauseCompletedNCT04537351Phase 1
- Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)CompletedNCT04534569
- Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 InfectionTerminatedNCT04526912Phase 1
- MSC-based Therapy in COVID-19-associated Acute Respiratory Distress SyndromeStatus unknownNCT04525378Phase 1
- COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2Status unknownNCT04524156Not applicable
- Blood Volume Assessment in COVID-19 and Bacterial SepsisCompletedNCT04517695
- Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
- Nebulised Heparin to Reduce COVID-19 Induced Acute Lung InjuryCompletedNCT04511923Phase 1/2
- Telmisartan in Respiratory Failure Due to COVID-19CompletedNCT04510662Phase 2
- Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS PatientsWithdrawnNCT04508933
- Helmet vs Face Mask in Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04507802Not applicable
- Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress SyndromeStatus unknownNCT04503876Not applicable